By Morgan Nwanguma Researchers at USF Health have identified a previously unknown way opioid receptors function, an advance that could pave the way for safer […]
Tag: pharmatimes
Clove: Natural, Beneficial But Not Harmless
By Deborah Bamisaye “Again?” the cup groaned. “This is the third time today.” The clove stretched in the hot water. “I used to be seasoning […]
BP: Left Vs Right Arm – The Overlooked Error That Distorts Diagnosis
By Deborah Bamisaye “Sorry mummy, they will soon attend to you.” The elderly woman shifted slowly on the plastic chair; her face tight with discomfort. […]
Pre-eclampsia and Hypertension in Pregnancy: Early Detection Saves Lives
By Evans Matthews Pregnancy is often described as a beautiful journey, yet for millions of women worldwide, it can also present life-threatening complications. Among these, […]
Obesity and Metabolic Syndrome in Male Patients
By Evans Matthews Obesity has become one of the most pressing public health challenges of the 21st century, and its impact on male health is […]
Jaundice in Newborns: When to Worry and how it’s treated
By Evans Matthews A yellowish tinge to a newborn’s skin or eyes can be alarming for new parents. Known medically as neonatal jaundice, the condition […]
The Pharmacological Future of Longevity
By Evans Matthews The pursuit of longer, healthier lives has shaped human history for centuries, but today, that ancient dream is accelerating toward reality. Thanks […]
Nigeria’s Pharmaceutical Industry: A $10 Billion Dream
By Chigbu Nwaobia Nigeria’s pharmaceutical industry is on the cusp of a major transformation, with projections indicating a five fold expansion to $10 billion over […]
Maternal Health and Safe Childbirth: Protecting Mothers, Shaping the Future
By Evans Matthews Maternal health remains one of the most powerful indicators of a nation’s well-being. Yet every day, an estimated 800 women worldwide die […]
Biologics Versus Biosimilars
By Evans Matthews In the rapidly evolving landscape of global healthcare, few topics have generated as much debate and excitement as the rise of biosimilars […]
